FDA grants full approval for Pfizer's cervical cancer drug

The U.S. Food and Drug Administration (FDA) granted full approval for Pfizer's (PFE.N) drug for treating cervical cancer patients whose disease had progressed on or after chemotherapy, the agency said on Monday.